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Abstract
Objective: The vascular system is adapted to specific functions in different tissues and organs. Vascular endothelial cells are
important elements of this adaptation, leading to the concept of ‘specialized endothelial cells’. The phenotype of these cells
is highly dependent on their specific microenvironment and when isolated and cultured, they lose their specific features
after few passages, making models using such cells poorly predictive and irreproducible. We propose a new source of
specialized endothelial cells based on cord blood circulating endothelial progenitors (EPCs). As prototype examples, we
evaluated the capacity of EPCs to acquire properties characteristic of cerebral microvascular endothelial cells (blood-brain
barrier (BBB)) or of arterial endothelial cells, in specific inducing culture conditions.
Approach and Results: First, we demonstrated that EPC-derived endothelial cells (EPDCs) co-cultured with astrocytes
acquired several BBB phenotypic characteristics, such as restricted paracellular diffusion of hydrophilic solutes and the
expression of tight junction proteins. Second, we observed that culture of the same EPDCs in a high concentration of VEGF
resulted, through activation of Notch signaling, in an increase of expression of most arterial endothelial markers.
Conclusions: We have thus demonstrated that in vitro culture of early passage human cord blood EPDCs under specific
conditions can induce phenotypic changes towards BBB or arterial phenotypes, indicating that these EPDCs maintain
enough plasticity to acquire characteristics of a variety of specialized phenotypes. We propose that this property of EPDCs
might be exploited for producing specialized endothelial cells in culture to be used for drug testing and predictive in vitro
assays.
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Introduction
According to their specific functions, different organs establish
during development instructive interactions with the circulatory
system, leading to the generation of blood vessels displaying
different specific features. Depending upon genetic predisposition
and microenvironmental influences, immature endothelial cells
have the ability to differentiate into specialized subpopulations
with gene expression profiles characteristic of different vascular
types [1–3]. The post-natal vascular system is thus heterogeneous,
and depending on their anatomic localisation, endothelial cells
have acquired specialized functions. Some endothelial cells like
human umbilical vein or artery endothelial cells (HUVECs or
HUAECs), are easy to isolate, but others, such as brain endothelial
cells are not. Moreover, when isolated and cultured, these
specialized mature endothelial cells rapidly lose their specific
differentiated features after only a few passages, limiting the
usefulness of these cultures for producing predictive and repro-
ducible pharmacological models.
Circulating endothelial progenitor cells (EPCs) are mobilized
from the bone marrow and are able to integrate into vascular
structures at sites of neovascularisation where they differentiate
into endothelial cells and proliferate [4,5]. Many studies suggest
that the physiological function of EPCs is the maintenance of
vascular integrity [6–10]. Cord blood EPC-derived endothelial
cells (EPDCs) isolated from human umbilical cord blood can be
extensively expanded in vitro. When compared to mature vessel
endothelial cells, such as HUVECs, EPDCs express endothelial
markers to a similar extent, except for KDR, which is expressed at
a higher level in EPDCs [11]. Moreover, they displayed a higher
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proliferation potential. Functional studies also have demonstrated
that these cells are more sensitive to angiogenic factors, conferring
to EPDCs a better viability than HUVECs [11]. Furthermore,
compared to equivalent cells isolated from adult peripheral blood,
those from cord blood give rise to a higher number of colonies.
Moreover, only cord blood EPCs, when seeded under limiting
dilution conditions, give rise to secondary and tertiary colonies:
these observations suggest that cord blood EPCs still display
properties of immature cells [12,13]. In this study, we explore the
hypothesis that these cells might be induced to acquire features of
distinct specialized endothelial cells in vitro when exposed to
appropriate external instructive stimuli. Because such specializa-
tion might be of considerable interest for the development of new
in vitro models for drug testing, we focused the present study on
two distinct endothelial specialized phenotypes with potential
pharmacological value: the blood brain barrier (BBB) and arterial
phenotypes.
The BBB is responsible for strictly controlling the exchanges
between the blood and brain compartments, by preventing the
paracellular diffusion of hydrophilic solutes, mediating the active
transport of nutrients to the brain, effluxing hydrophobic
molecules and drugs from the brain to the blood and regulating
the trans-endothelial migration of circulating blood cells and
pathogens. Endothelial cells of cerebral blood vessels display a
unique phenotype characterized by the presence of intercellular
tight junctions and the polarized expression of numerous transport
systems [14,15]. In close proximity to brain ECs, pericytes, glial
cells (especially astrocytes), and neurons, together with the
basement membrane sheathing cerebral blood vessels, are directly
involved in the establishment and maintenance of the BBB. Most
in vitro BBB models currently available are based on primary
cultures of cerebral endothelial cells from different animal (bovine,
porcine, murine cells) and human sources, usually co-cultured with
glial cells in two-chamber cell culture systems [16–19]. In addition,
we previously developed the human hCMEC/D3 brain endothe-
lial cell line, which retains many morphological and functional
characteristics of brain endothelium, as a tentative in vitro model of
the human BBB [20–22]; indeed, this model has now been
validated and is widely used as a model of brain endothelium.
However, because of the limitations of this model, in particular its
relatively high paracellular permeability to small hydrophilic
compounds, there is still a real need to develop new models of
human BBB, based on primary culture of specialized endothelial
cells, both for studying mechanisms involved in BBB specialization
and for performing reliable and predictive pharmacological and
toxicological tests.
Specification of endothelial cells to an arterial or venous fate is a
crucial process during vascular development. With the discovery of
ephrin B2 (Efnb2) and its receptor ephrin B4 (Ephb4) as
biomarkers of arteries and veins, respectively, it appeared that
the specification of arteries and veins is determined by genetic
programs in the developing embryo before the appearance of the
circulation [23]. It has been shown that a high dose of VEGF
induces arterial specification by controlling Notch pathway
induction [24]. Numerous studies indicate that activation of
Notch signalling is essential to arterial specialization [25], [26].
Most studies which focused on the crucial role of signalling
cascades such as VEGF and Notch in arterial specification have
been performed on mouse embryonic stem cells [24,27,28]. A
recent study characterized the flow-induced transcriptional
response of EPCs. It showed that these cells do not resemble
mature arterial cells in their expression of specific differentiation
markers [29]. These results confirm that blood flow alone is not
sufficient for arterial specialization.
In the present study, we demonstrate that human cord blood
EPCs retain an immature phenotype, allowing them to further
differentiate in vitro, upon instruction by appropriate stimuli,
towards various specialized phenotypes such as BBB or arterial
endothelial phenotypes.
Materials and Methods
Cell Isolation and Culture
Mononuclear cells (MNCs) were isolated from human cord
blood (all anonymous donors gave informed consent for all
procedures and samples) by Ficoll (Pancoll, Dutscher, France)
density gradient centrifugation (400 g, 30 min, 20uC, no frame)
and were resuspended in endothelial growth medium (EGM2-
MV) (Lonza, Verviers, Belgium) [9]. The cells were then plated at
a cell density of 5.26106/cm2 onto separate wells of a 12-well
tissue culture plate precoated with type I rat tail collagen (BD
Biosciences, Le Pont de Claix, France) and maintained at 37uC,
under 5% CO2, in a humidified incubator. In order to eliminate
non-adherent cells and debris, the medium was aspirated after 24
hours of culture, wells were washed with PBS 1X and fresh
complete EGM-2 medium was added to each well. The medium
was changed daily for 7 days and then every other day. Wells were
inspected daily for the outgrowth of endothelial colony-forming
cells (ECFC). ECFC colonies appeared between 8 and 12 days of
culture and were characterized by formation of a cluster of
cobblestone-appearing cells.
Human samples were collected and handled in the full respect
of the declaration of Helsinki. Cord blood used for endothelial cells
preparation is managed through partnership with The Cord Blood
Bank of St Louis Hospital. This cord blood bank is authorized by
French Regulation Agency (authorization Nu PPC51) and
participates to scientific research. This activity has been declared
to and authorized by French Ministry of Research under number
AC-2008-376, and to the French Normalization Agency under
number 201/51848.1. The mothers’ written informed consents
are kept by the mother, the maternity administration and the Cord
Blood Bank of St Louis Hospital.
HUVECs and HUAECs were isolated according to the method
of Jaffe et al. [30] and cultured in EGM2-MV. hCMEC/D3 were
established as described [21] and cultured in EBM2 medium
(Lonza) supplemented with 5% FBS ‘‘Gold’’ (PAA Laboratories
GmbH, A15–151), 10 mM HEPES (PAA Laboratories GmbH),
1% Penicillin-Streptomycin, 1% chemically defined lipid concen-
trate (Invitrogen Ltd, Paisley, UK), 1.4 mM hydrocortisone, 5 mg/
ml ascorbic acid, 1 ng/ml bFGF (Sigma-Aldrich, St. Louis, MO)
and 10 mM lithium chloride (Merck). Human aortic endothelial
cells (HAECs) were purchased from ScienCellTM Research
Laboratories (cat. 6100, San Diego, CA) and cultured in EGM2-
MV. Primary cultures of astrocytes were prepared from the
cerebral cortex of newborn rats as previously described [31].
Three weeks after seeding, astrocytes were trypsinized and frozen
in liquid nitrogen.
Flow Cytometry
EPDCs were detached with trypsin and immunophenotyping
was assessed by using the following monoclonal antibodies: CD31-
FITC (1:25, BD Pharmingen, 555445), CD144-PE (1:10, Beck-
man Coulter, A07481), anti-KDR-APC (1:5, R&D Systems,
FAB357A). Antibodies and matched isotype control (Beckman
Coulter) were incubated for 30 min at 4uC. Viability was assessed
with 7-AAD (Becton Dickinson). Data were acquired and analyzed
on a five-parameter flow cytometer (FACScalibur, Becton
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Dickinson, San Jose, CA) with Weasel software (WEHI,
Melbourne, Australia).
Immunofluorescence Staining
Cells were fixed in 4% paraformaldehyde/PBS for 10 minutes
at room temperature and rinsed with PBS 1X. For intracellular
staining, cells were permeabilized with 0.1% Triton X100/PBS for
10 minutes at room temperature. Cells were incubated over night
at +4uC with antibodies anti-CD144 (1:200, Beckman Coulter,
IM1597), anti-CD31 (1:20, BD Pharmingen, 550389), anti-ZO1
(1:200, BD Biosciences, 610966), anti-CL3 (1:100, Abcam,
C0144), anti-CL5 (1:100, Invitrogen, 34–1600), anti-OCCL
(1:100, Invitrogen, 33–1500), anti-EFNB2 (1:10, R&D Systems,
AF467), anti-NRP1(1:20, R&D Systems, AF3870), anti-HEY2
(1:50, Santa Cruz Biotechnology, sc-28747), anti-ANGPT2 (1:20,
R&D Systems, AF623), anti-CXCR4 (1:100, Abcam, ab2074),
anti-COUP-TFII (1:100, R&D systems, PP-H7147-10), anti-
EPHB4 (1:10, R&D systems, AF3038) or anti-NRP2 (1:40, R&D
Systems, AF2215) antibodies diluted in 3% BSA/PBS and, after 5
PBS 1X washes, labeled with secondary antibodies Alexa Fluor
488 IgG (Invitrogen, Cergy-Pontoise, France). Cells were then
stained with 2 mg/mL of 40,6-diamidino-2-phenylindole (DAPI)
and examined with a DMR fluorescence microscope (Leica, Rueil
Malmaison, France) equipped with a CoolSnap HQ2 camera
(Photometrics, Tucson, AZ) controlled by MetaVueH Analyzing
Software (Molecular Devices LLC, Sunnyvale, CA).
Vascular Tube Formation
Twelve-well plates were coated with Matrigel (BD Biosciences,
San Diego, CA). EPC-derived cells were detached by trypsin-
EDTA treatment and seeded onto Matrigel in EGM-2 at a cell
density of 2.105 cells per well. EPDCs were incubated at 37uC and
viewed after 4 hours by visual microscopy for observation of
capillary-like formation.
Ac-LDL Uptake
Incorporation analysis of acetylated low-density lipoprotein 488
(Ac-LDL 488; Invitrogen) was performed to assess the incorpora-
tion ability of EPDC. Cells were incubated with 15 mg/ml of Ac-
LDL 488 in endothelial medium for 4 h at 37uC, washed three
times in PBS, fixed for 10 minutes with 4% paraformaldehyde and
mounted with Glycergel mounting medium (Dako, Trappes,
France) containing 2 mg/mL DAPI. Ac-LDL uptake was moni-
tored with a DMR fluorescence microscope (Leica, Rueil
Malmaison, France) equipped with a CoolSnap HQ2 camera
(Photometrics, Tucson, AZ) controlled by MetaVueH Analyzing
Software (Molecular Devices LLC, Sunnyvale, CA).
Co-culture of Human Endothelial Cells and Rat Astrocytes
Astrocytes were thawed and seeded (8.104 cells/cm2) into the
bottom of 6-multiwell plates four days before endothelial cell
seeding. EPDCs, HUVECs or HAECs at passage 2 were then
seeded on collagen IV–fibronectin (0.1 mg/mL and 0.02 mg/mL,
respectively)-coated well Millicell inserts (Well MillicellH Hanging
Cell Culture Inserts, polyester (PET), pore size 1 mm, ref.
PIRP30R48) in complete EGM2-MV (LONZA) medium supple-
mented with 1.4 mM hydrocortisone (a concentration higher than
physiological levels, but previously identified as the optimal
concentration for BBB differentiation of brain endothelial cells
[32]) at a cell density of 4500 cells/cm2. Three or four days later,
when endothelial cells reached confluence, half of the medium was
replaced by the less proliferative EBM2+ medium (EBM2+
FBS+bFGF+hydrocortisone, Lonza). EBM2+ medium was not
supplemented with VEGF. Half of the medium was changed every
3 days, up to 14 days of culture.
In control wells, endothelial cells were seeded under the same
conditions, but without astrocytes.
Permeability Studies
To measure the paracellular passage of Lucifer Yellow (LY,
457 kDa), a water soluble small fluorescent marker, or of standard
fluorescent polar molecules of increasing molecular masses (FITC-
Dextran 4 kDa and 70 kDa; Sigma-Aldrich, St. Louis, MO) across
the endothelial monolayer, cell culture inserts containing special-
ized EPDCs, HUVECs or HAECs at passage 2 were transferred
into new 6-well plates containing 4.2 mL pre-warmed HBSS/
HEPES (1 mM) buffer. At time zero, the culture medium of the
upper compartment is removed and replaced by 2 mL of same
buffer containing 25 mM of LY, 10 mM FITC-Dextran 4 kDa or
0.25 mM FITC-Dextran 70 kDa molecules. The inserts were
transferred at 10, 20, 30, 40 and 60 min to new wells containing
the assay buffer. Permeability of LY was also measured on cell-free
inserts coated collagen IV–fibronectin. The concentration of the
fluorescent marker molecule in samples from the upper and lower
compartments was measured with fluorescence multiwell plate
reader (excitation: 485 nm, emission: 535 nm). Permeability
calculations were made following the clearance principle as
described by Siflinger et al. [33] to obtain a concentration-
independent permeability value.
Calcein-AM Uptake
To assess P-gp activity, EPDCs and hCMEC/D3 cells were pre-
incubated for 30 min at 37uC in presence or absence of Verapmil
(40 mM) (Focus Biomolecules, #10–1111), a P-gp inhibitor. After
this pre-incubation, 1 mM of the cell-permeant dye Calcein-AM
(AnaSpec, #89202) was added in the medium for 60 min. The
cells were then washed 3 times with ice-cold PBS and lyzed on ice
with Triton-X100 5% for 20 min. After scrapping and resuspen-
sion in a needle, cell extracts were centrifuged for 5 min at 4uC
and cellular accumulation of the P-gp substrate Calcein (produced
from Calcein-AM after hydrolysis by intracellular esterases) was
assessed by fluorescence measurement of the supernatants
(excitation: 495 nm; emission: 516 nm) with a Mithras LB 940
(Berthold) spectrophotometer. The P-gp activity is reflected by an
increased cellular accumulation of the fluorescent Calcein in
presence of the inhibitor Verapamil.
EPDC Arterial Specialization
To induce arterial specification, EPDCs colonies were trypsin-
ized and then cultured in EGM-2 medium containing 50 ng/mL
of VEGF (VEGF-165, PromoKine, C-64420) for one or two
passages. Analysis of the expression of arterial and venous markers
was then performed. To inhibit arterial differentiation, 50 mM
DAPT (InsolutionTM c-Secretase Inhibitor IX, Calbiochem,
565784), a Notch signaling inhibitor, was added to EPDCs at
passage 1, during culture in the presence of 50 ng/mL VEGF.
RNA Isolation and Quantitative Polymerase Chain
Reaction
Total RNA of all cell types was isolated using the RNeasy H Plus
Mini Kit (Qiagen, ref. 74134/RNase-Free DNase set, ref. 79254).
Following isolation, RNA concentration was quantified using
NanoDropH ND-1000 Spectrophotometer technology. For
HUAECs (Human Umbilical Arterial Endothelial Cells) and
HUVECs (Human Umbilical Venous Endothelial Cells), cDNA
was prepared with the High Capacity cDNA Reverse Transcrip-
Induction of Endothelial Progenitor Specialization
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tion Kit (Applied Biosystems, ref. 4368814) using 1 mg of total
RNA, and the Quantitative polymerase chain reaction was
performed with TaqManH microfluidic cards (TaqMan Low
Density Array: TLDA, Applied Biosystems) on an ABI7900 system
at the Service de Ge´ne´tique Mole´culaire, Hoˆpital du Kremlin-
Biceˆtre, France. Genes of interest were then selected and results
were confirmed with Gene Expression Assays (4331182, Applied
Biosystems) using the Taqman Universal MasterMix II (4440047,
Applied Biosystems) in an ABI7300 system (Applied Biosystems) in
the presence of 10 ng of initial RNA. Accession numbers of
TaqMan assays are presented in Table1. Gene expression was
measured using the 2-[/delta][/delta]Ct method. For the
hCMEC/D3 cell line, cDNA was prepared with Superscript II
Reverse Transcriptase (Invitrogen, ref. 18064014) using between
100 and 150 ng of total RNA, and the quantitative polymerase
chain reaction was performed with LightCycler480 Sybr Green I
MasterH kit (Roche, ref. 04707516001) in a LightCycler 480
system on the genomic platform of the Institut Cochin, France.
Western Blot Analysis
Cell lysates were prepared using 200 mL Laemmli 2X buffer
with benzonase, directly on inserts, maintained on ice, for 10 min.
After scraping, cell supernatants were harvested and denatured at
100uC for 5 min. Proteins were analyzed on 8% SDS–PAGE gels
and blotted on nitrocellulose membranes (Amersham Biosciences).
After protein transfer, unspecific binding sites were blocked by
incubation in TBS-T (50 mM Tris/HCl, 150 mM NaCl)
containing 0.05% Tween 20 and 5% skimmed milk for 1 hour
at room temperature. Washed membranes were incubated
overnight at 4uC with antibody against P-Glycoprotein C219
(1:20, Thermoscientific, MA1-26528), occludin (1:100, Santa Cruz
Biotechnology, sc-133255) or Glut-1 (1:200, Epitomics, 2944S).
Four washes were performed in 0.05% TBS-T. Following 1 hour
incubation with HRP-conjugated secondary anti-mouse or rabbit
antibody (1:5000 in 2.5% skimmed milk), the target protein was
revealed by chemiluminescence HRP substrate (ECLTM Western
Blotting Detection Reagents, Amersham Biosciences). Quantifica-
tion was performed on scanned immunoblot using ImageJ
software.
Statistical Analysis
All data are presented as the mean 6 SEM. Comparisons
between groups were performed using unpaired student’s t-tests. P
values less than 0.05 were considered significant.
Results
1) EPDCs Isolation and Characterization
Cord blood EPCs-derived endothelial cells EPDCs [11] also
described as ECFC [12] formed primary colonies (Fig. 1A) that
appeared between days 8 and 12 and reached confluence at day
15–20 (Fig. 1B). At this stage, monolayers of confluent cells
displayed the typical morphology of endothelial cells. After 2
passages, EPCs were characterized by flow cytometry for
expression of specific endothelial markers such as KDR and
CD144 (Fig. 1C). Most cells expressed these specific cell surface
endothelial markers. Immunofluorescence microscopy showed
characteristic CD144 and CD31 membrane expression on most
cells of the monolayer (Fig. 1D and 1E). We then expanded these
EPDCs during 2 additional passages to confirm they cells maintain
features of functional endothelial cells. When EPCs were
cultivated on Matrigel, they formed typical vascular-like network
structures after 4 hours. Moreover, they showed uptake of
diacetylated low-density lipoprotein (LDL) (Fig. 1G). These results
confirmed that EPDCs displayed typical phenotypic and func-
tional properties of endothelial cells.
2) BBB Specialization
a. Functional characterization. EPDCs are stem cell
derived endothelial cells that have not yet acquired a specialized
phenotype, resembling in that aspect embryonic angioblasts that
acquire their specific functional features through induction with
organ-specific local signals. For brain tissue, interaction of brain
microvascular endothelial cells with astrocytes and pericytes is
important to induce BBB specification. To mimic these environ-
mental stimuli in culture, we have developed a two-compartment
culture system: EPDCs at passage 2 were seeded onto collagen/
fibronectin-coated polyester inserts with rat astrocytes in the lower
compartment (Fig. 2A). Co-cultures were then grown in complete
endothelial medium until cells reached confluence; EPDCs and
astrocytes were then switched to a less proliferative medium up to
14 days to favor maximal ‘‘education’’ in co-culture.
One of the major characteristics of BBB endothelial cells is their
strictly limited paracellular permeability (Pe) to hydrophilic
compounds, due to their intercellular tight junctions (TJ),
comprising proteins such as Zonula Occludens (ZO-1), claudin-5
(CL5) and occludin (OCCL), in addition to adherens junctions (AJ)
that contain proteins like VE-cadherin. Permeability was assessed
by measuring the passage of a water soluble small fluorescent
marker (Lucifer Yellow (LY): MW 457 Da) through confluent
monolayers of EPDCs. We identified an optimal time window
between day 10 and day 14 of co-culture, when Pe exhibited the
Table 1. Accession numbers of TaqManH (Applied
Biosystems) assays used for the quantitative-PCR.
Genes Assay IDs
ANGPT2 Hs01048042_m1
VE-CAD (CD144) Hs00174344_m1
CD34 Hs00156373_m1
COUP-TFII (NR2F2) Hs00819630_m1
CXCR4 Hs00976734_m1
DLL4 Hs00174344_m1
EFNB2 Hs00187950_m1
EPHB4 Hs00174752_m1
HES1 Hs00172878_m1
HES2 Hs00219505_m1
HEY1 Hs00232618_m1
HEY2 Hs00232622_m1
JAG1 Hs00164982_m1
KDR (VEGFR2) Hs00176676_m1
LMOD1 Hs00201704_m1
MMP9 Hs00234579_m1
NOTCH3 Hs00166432_m1
NOTCH4 Hs00270200_m1
NRP2 Hs00187290_m1
PECAM (CD31) Hs00169777_m1
PLGF Hs01119262_m1
RPLP0 Hs99999902_m1
SELP Hs00927900_m1
doi:10.1371/journal.pone.0084179.t001
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lowest values (Fig. 2B). During this period, at each point of the
kinetics, the presence of astrocytes significantly decreased the Pe
value, as compared to EPDCs cultured alone. Moreover, we
showed the lowest permeability (1.2361023 cm/min) was ob-
served at 14 days of co-culture, which correlates well with the
morphology of EPDC at this time (Fig. 2D). Indeed, after 14 days
of culture, the morphology of EPDCs co-cultured with astrocytes
was different from that of EPDCs cultivated alone. Co-cultured
Figure 1. EPDC’S phenotypical and functional characterization. (A) Primary colony’s phase contrast micrograph. (B) EPDC’s monolayer at
passage 2. (C) Expression of specific endothelial markers (KDR, CD31/PECAM and CD144/VE-CAD) by flow cytometry. (D) CD31, (E) CD144
immunofluorescence staining. (F) Vascular-like network structures after 4 hours on Matrigel. (G) Characteristic diacetylated low-density lipoprotein
incorporation.
doi:10.1371/journal.pone.0084179.g001
Figure 2. Barrier properties of specialized EPDCs. (A) Schematic representation of EPDCs in vitro two-compartment differentiation BBB model.
(B) Time course of transendothelial permeability for the water soluble small fluorescent marker LY in EPDCs cultured alone (purple) or with astrocytes
(blue). (**p,0.001, ***p,0.0001; EPDC permeability measures were performed on 5 independent experiences each individual experience was
performed in triplicate). Confluent EPDC’s monolayers cultured alone (C) or with astrocytes during 14 days (D). (E) LY permeability measurement for
EPDCs, HUVECs and HAECs cultured alone (left) or with astrocytes (right) (HUVEC and HAEC permeability measures were performed on 2
independent experiences and each individual experience was performed in triplicate). Scale bar: SEM.
doi:10.1371/journal.pone.0084179.g002
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EPDCs appeared smaller and the monolayer appeared tighter
than with EPDCs alone (Fig. 2C and 2D). However, beyond 14
days, endothelial cells begin to suffer and to degenerate
morphologically, and some of them detach from the filter.
Using hCMEC/D3 cells as an available reference BBB model,
we measured permeability to LY which was similar to that
observed in the EPDC based model (1.461023 cm/min).
To check the robustness of our model, we performed the same
BBB-instruction protocol using mature endothelial cells of venous
or arterial origin, HUVECs and HAECs (human aortic endothe-
lial cells). In order to avoid cell detachment, LY permeability of
HUVECs and HAECs was measured at day 10 of culture. We
showed that HUVECs’ permeability, alone or co-cultivated with
astrocytes, was equivalent to that of EPDCs cultured alone,
whereas permeability of HAECs was higher (Fig. 2E). In contrast
to EPDCs, co-culture with astrocytes did not improve permeability
values for HUVECs and HAECs. This result indicates that
EPDCs, in contrast to HUVECs or HAECs, are specifically
responsive to the instructive induction of astrocytes. However, as
for the hCMEC/D3 cell line, we measured low TEER values
(inferior to 60 V/cm2, data not shown).
b. Phenotypic characterization. To validate the BBB
phenotype of EPDC, we assessed the expression of barrier specific
TJ proteins (CL5, ZO-1 and OCCL) and transporters (GLUT1,
BCRP and P-glycoprotein: P-gp) by quantitative RT-PCR
(Fig. 3A). OCCL expression was increased when EPDCs were co-
cultured with astrocytes for 14 days. In the same way, GLUT1, the
primary transporter of glucose present on the BBB, showed an
increased expression in the astrocyte co-cultures. Although the
expression of ZO-1, CL5 (TJs proteins) and BCRP transporter were
unchanged in EPCs cultured alone or with astrocytes, we noticed
that their levels of expression were similar to that observed in
hCMEC/D3 cells. Overexpression of Axin-2 in co-cultured EPCs
suggested that the canonical Wnt/b-catenin pathway is activated
in this model, in line with the recent demonstration that this
pathway is required for BBB formation during development.
Moreover, in terms of the expression of P-gp, an active efflux
transporter involved in BBB function, we detected by qPCR a very
low level of expression as compared to the hCMEC/D3 cells (data
not shown). We thus investigated P-gp protein expression by
western blot and showed an increased protein level in EPDCs co-
cultured with astrocytes compared to EPDCs cultured alone
(Fig. 3B). Moreover, western blot experiments confirmed higher
expression of GLUT1 and OCCL proteins in EPDCs co-cultured
with astrocytes.
P-gp activity was evaluated by a Calcein uptake assay: as
described in the Materials and Methods Section, the cell-
permeant, non-fluorescent dye Calcein-AM is converted to the
fluorescent Calcein, a P-gp substrate, by intracellular esterases.
Here (Fig. 3N), in the presence of Verapamil, a P-gp inhibitor, we
observed a significantly increased intracellular Calcein level in
EPDCs, revealing the activity of the efflux transporter P-gp. More
interestingly, this increase was stronger in EPDCs co-cultured with
rat astrocytes (1.40-fold increase) than in EPDCs cultured alone
(1.23-fold increase): this observation extends the above result by
establishing that P-gp activity in EPDCs is enhanced by co-culture
with astrocytes. For comparison, in hCMEC/D3 reference cells,
the Verapamil-induced increase in the intracellular Calcein was
1.80-fold.
AJ and TJ protein expression after 14 days of culture was
assessed by immunofluorescent staining. Co-cultured EPDCs
showed a more continuous expression of VE-cadherin, ZO-1,
claudin-3 (CL3), CL5 and OCCL at cell-cell contact (Fig. 3D–L),
typical of BBB endothelial cells, whereas EPDCs cultured alone
showed a more diffuse and less continuous staining (Fig. 3C–K);
this observation suggests that endothelial cell-cell junctions
undergo maturation in the presence of astrocytes.
As mentioned above, the extremely low permeability of the BBB
in situ is directly related to the existence of TJs between cerebral
endothelial cells which restrict the passive diffusion of polar
molecules from blood to brain tissue in a size-selective manner.
We tested the permeability of this EPDC-model to standard
fluorescent polar molecules of increasing molecular masses (LY:
457 Da, FITC-Dextran 4 kDa and FITC-Dextran 70 kDa). Our
results indicated (Fig. 3M) that, as expected, the permeability of
human EPDCs was inversely related to the mass of the polar
compound tested. Co-culture with rat astrocytes significantly
reduced the LY permeability of EPDCs to a similar level as the
reference hCMEC/D3 cell line. The low permeability to large
molecules of Dextran of the EPDC monolayer did not allow for
the detection of any significant further reduction by co-culture
with rat astrocytes. This phenotypic and functional characteriza-
tion indicates that EPDCs can be educated by glial cells to express
several BBB markers, suggesting that human cord blood EPCs
constitute a previously unrecognized source of cells that could
ultimately lead to new in vitro models of human BBB.
3) Arterial Specialization
a. Expression profile of HUAECs and EPDCs compared to
HUVECs. It is now established that a molecular imprinting of
arterial and venous identities exists prior to the establishment of
blood circulation. Arterial and venous specific markers have been
identified, such as the Ephrin-B2 ligand (EFNB2), specifically
expressed in the arteries, and its receptor, Ephrin-B4 (EPHB4),
more restricted to venous endothelial cells.
In order to have access to a specific pattern of arterial and
venous specific genes, we screened the expression of sixty selected
genes using TaqManH microfluidic cards on HUAECs and
HUVECs. We also established the native gene expression profile
of EPDCs under standard culture conditions. This expression
profile was performed on early passages because arterial special-
ization markers decreased with passage number in the absence of
flow conditions during culture. HUVECs and HUAECs each
showed distinctive mRNA expression patterns. We confirmed the
expression of several genes already known to have arterial/venous
specificity, such as EFNB2 and Notch signaling components (Fig. 4)
and identified new arterial markers.
Indeed, expression of six genes appeared to be up-regulated in
HUAECs (Fig. 4B and 4C). The CXCR4 (C-X-C chemokine
receptor type 4) gene was expressed almost 60 times more in
HUAECs than in HUVECs. We also found an increased
expression of CD34 cell surface marker in HUAECs. This
molecule is selectively expressed on human hematopoietic
progenitor cells but also on vascular endothelial cells.
PlGF (Placental Growth Factor) belongs to the family of the vascular
endothelial growth factor members. Our results showed that this
gene was up-regulated in HUAECs compared to HUVECs. We
also observed an increased level of expression of LMOD1 (Leiomodin
1) in HUAECs as compared to HUVECs, which correlated with
the protein expression in mouse aorta [34]. MMP9 (Matrix
Metalloproteases 9), which degrades the extracellular matrix to
allow for endothelial sprouting, is essential for angiogenesis.
HUAECs expressed this gene almost 3 times more than did
HUVECs. Lastly, we identified ANGPT2 as an arterial marker in
our model.
Well known venous markers have been confirmed in our model,
such as COUP-TFII, NRP2 and EPHB4 (Fig. 4A and 4C). We also
identified a new venous marker, SELP (Selectin-P), which belongs
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to the family of the cellular adhesion molecules. SELP was
significantly decreased in HUAECs as compared to HUVECs.
This protein mediates the interaction of activated endothelial cells
with leukocytes.
Figure 3. Specialized EPDC’s BBB characteristics. (A) Quantitative RT-PCR expression analysis of specific BBB genes at day 14 of culture, in
EPDCs alone (purple), with astrocytes (blue) and hCMEC-D3 (green) (qRT-PCR were performed on EPDCs RNA isolated from 6 BBB differentiation
independent experiences, each individual experience was performed in triplicate). (B) Western blot of P-gp, GLUT-1 and OCCL in EPDCs alone (purple)
or with astrocytes (blue) at day 14. Densiometric quantification was performed for each immunoblot using ImageJ software. (C–L) VE-CAD, ZO1, CL3,
CL5 and OCCL immunofluorescence staining in EPDCs alone (C–G) or with astrocytes (H–L). Arrows show continuous junctions. (M) Permeability for
LY (0.457 kDa) and Dextran-FITC (4 and 70 kDa) in EPDCs alone (purple) or with astrocytes (blue) and in hCMEC/D3 (green) (EPDC permeability to
dextran-FITC molecules was performed once in triplicate). (N) Accumulation of Calcein into EPDCs alone or with astrocytes, in the presence (hatched
area) or absence of Verapamil (**p,0.001; a.u: arbitrary units). Scale bar: SEM.
doi:10.1371/journal.pone.0084179.g003
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Expression of these new arterial and venous markers has been
investigated in our EPDC-derived arterial model.
Analysis of gene expression in EPDCs showed an intermediate
profile between HUAECs and HUVECs. Indeed, expression of
COUP-TFII and SELP venous markers was roughly similar to that
in HUAECs (Fig. 4A and 4C). In contrast, venous markers NRP2
and EPHB4 were expressed at levels close to that of HUVECs.
Analysis of arterial marker expression showed that some genes,
such as PLGF, HES2, CD34 or CXCR4 were expressed at levels
close to that of HUAECs, whereas expression of ANGPT2, EFNB2,
JAG1, LMOD1 and HEY2 was closer to HUVECs (Fig. 4B and
4C). In this context, we decided to assess whether EPDCs, which
in steady state culture conditions presented an intermediate
arterio-venous phenotype, could be differentiated to an arterial
phenotype by inductive culture conditions.
b. Arterial specialization of EPDCs. The goal of this part
of work was to demonstrate that EPDCs can be specialized into an
arterial phenotype by using a simple and reproducible culture
method. Several studies have shown that VEGF and Notch
signaling were strongly implicated during arterial specification. We
thus treated EPDCs with various concentrations of VEGF as early
as at passage 1 after EPDC colonies appeared. EPDCs were grown
for one or two passages under these conditions and then analysis of
the expression of arterial and venous markers was performed. As
shown in figure 5A, expression of venous markers detected by
qRT-PCR was not modified by the presence of high concentra-
tions of VEGF in the culture medium. In contrast, we noticed that
expression of most canonical arterial genes, such as EFNB2 and
Notch signaling components was significantly up-regulated. Ex-
pression of the new arterial markers identified in HUAECs
cultures, ANGPT2, CD34 and CXCR4 (except PLGF) was also
increased in EPDCs treated with higher concentrations of VEGF.
To confirm that this VEGF-dependent induction of arterial genes
was directly related to the activation of Notch signaling in EPDCs,
we added the Notch inhibitor DAPT with EPDCs from passage 1,
in the presence of high amount of VEGF (50 ng/mL). Indeed,
DAPT decreased the expression of arterial markers and increased
that of the venous markers COUP-TFII and NRP2. Among all the
genes whose expression was increased by VEGF treatment and
decreased with DAPT, we could identify DLL4, a ligand of Notch
signaling, the receptor NOTCH3 and 3 Notch effectors, HES1,
HEY1 and HEY2. These results confirmed the strong implication
Figure 4. Gene expression profile from HUAECs and EPDCs compared to HUVECs. (A) Sixty genes were analyzed using TaqManH
microfluidic cards on early passages HUAECs and EPDCs. Figure 4 shows selection of 17 selected genes confirmed by Gene Expression Assays. Results
were expressed as the ratio of expression between HUAECs vs HUVECs (light grey) and EPDCs vs HUVECs (dark grey). (A) Expression of venous (blue)
and (B) arterial (red) markers (scale bars: SEM). (C) Table of numeric values. (*p,0.05, **p,0.001, ***p,0.0001) (qPCR expression analysis were
performed at least 3 times, on independent cells batches and each time in triplicate).
doi:10.1371/journal.pone.0084179.g004
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of the Notch pathway in this EPDC specialization model.
Moreover, the decreased expression of all arterial markers
observed with DAPT treatment in presence of a high concentra-
tion of VEGF confirmed that Notch signaling was involved
downstream of VEGF in the arterial specialization.
These results were confirmed at the protein level. Indeed,
immunofluorescence assays showed that expression of arterial
markers, such as EFNB2, Nrp1, HEY2, ANGPT2 and CXCR4,
was up-regulated with high VEGF concentrations (Fig. 6A).
Although no variation of venous transcripts was observed by qRT-
PCR, extinction of venous markers COUP-TFII and EPHB4 in
the presence of higher VEGF concentrations was confirmed by
immunostaining. We also demonstrated that DAPT treatment
repressed arterial marker expression such as EFNB2, HEY2, and
CXCR4. Two other arterial genes, NRP1 and ANGPT2, which
variation of expression was not evidenced by qRT-PCR analysis,
appeared clearly repressed in immunofluorescence experiments
(Fig. 6B). Finally, we noted that upon Notch inhibition, the venous
markers COUP-TFII, EPHB4 and NRP2 were up-regulated.
Taken together, these results demonstrated that early passage
EPDCs cultured under VEGF-inductive conditions could adopt a
Notch dependent-specialized arterial phenotype, even in absence
of shear stress.
Discussion
EPDCs display the morphology and phenotype of endothelial
cells but their functional features indicate that although these cells
have undergone some differentiation steps, they still exhibit
properties of immature cells. In this study, we have demonstrated
that early passage EPDCs display significant plasticity, when
submitted to appropriate stimuli, being able to acquire, some
distinct characteristics of paradigmatic specialized endothelia:
brain or arterial endothelium.
To induce a phenotypic change towards BBB specialization, we
have developed an in vitro model where EPDCs at passage 2 were
grown on culture inserts and co-cultured with rat astrocytes, in the
lower compartment. To assess the extent of this phenotype
change, we tested several key properties such as the paracellular
permeability of the endothelial monolayer to hydrophilic com-
pounds. The restricted permeability observed with EPDCs co-
cultured with astrocytes (1.2361023 cm/min) correlated with
staining of intercellular TJ proteins, and was only observed in co-
culture conditions. These results are similar to those obtained with
the hCMEC/D3 cell line, an available in vitro model of the human
BBB [20–22] which we used here as a reference.
Moreover, we tested commercially available human astrocytes
in co-culture with EPDCs, but these cells failed to induce any
significant BBB specialization of EPDCs, as compared to rat
Figure 5. qRT-PCR Expression analysis of arterio-venous genes in EPDCs under arterial and venous inductive conditions. (A) Early
passages EPDCs were cultured in high (VEGF 50 ng/ml) or low (VEGF 10 ng/ml) VEGF concentration conditions and then, expression of arterio-venous
markers were analyzed. Results were expressed as the ratio of expression between high and low VEGF concentration culture conditions. (B) High
VEGF early passages EPDCs were cultured under 50 mM DAPT, a Notch signaling inhibitor, and then, expression of arterio-venous markers were
analyzed. Results were expressed as the ratio of expression between 50 mM and none DAPT conditions (green: endothelial, red: arterial, bleu: venous
markers). (Scale bars: SEM, *p,0.05, **p,0.001, ***p,0.0001) (qPCR expression analysis were performed at least 3 times, on independent cells
batches and each time in triplicate).
doi:10.1371/journal.pone.0084179.g005
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astrocytes. Further experiments would be required to definitively
assess whether human astrocytes may be used successfully in co-
culture with EPDCs. Nevertheless, co-culture models of endothe-
lial cells from human [35] or bovine [17] origin and rat astrocytes
have been successfully developed by other groups. These
observations suggest that putative species differences are unlikely
to impede the establishment of new valuable in vitro models of the
BBB.
One of the limitations of our model remains the low TEER
measured, similar to the hDMEC/D3 cell line, which nevertheless
presently constitutes a useful and widely used model of the human
BBB. However, we observed with EPDCs a very low permeability
to passively diffusing polar compounds (4 kDa or 70 kDa
Dextrans) and a reduced permeability to the low molecular weight
compound LY (400 Da) in co-culture with rat astrocytes. We also
showed that expression of the TJ protein OCCL, the glucose
transporter GLUT-1 and the active efflux transporter P-gp, three
markers of the BBB, were significantly increased in co-cultured
EPDCs. Finally, we report that P-gp activity, as assessed by
Verapamil-induced increase in the Calcein intracellular level, was
significantly enhanced by co-culture with rat astrocytes.
Although we did not detect, by qPCR, significant differences in
the expression of ZO1, CL5 and the BCRP transporter between
EPDCs cultured alone and co-cultured with astrocytes, we
observed that their levels of expression were similar to those of
control hCMEC/D3 cells. In line with the recent demonstration
that the canonical Wnt/b-catenin pathway is implicated in BBB
induction [36], high expression in co-cultured EPDCs of AXIN-2,
a primary target gene of the Wnt/b-catenin pathway suggested
that this essential pathway was indeed activated in ‘educated’
EPDCs. Moreover, immunofluorescence staining of AJ and TJ
revealed a typical labeling of BBB endothelial cells. CL3, CL5 and
OCCL staining appeared even more continuous at cell-cell
contacts compared to hDMEC/D3 [21]. Taken together, these
results showed that co-culture of early passages EPDCs with
astrocytes induced a phenotypic change towards a BBB pheno-
type. As this work was being completed, Lippmann et al.
independently reported the derivation of BBB endothelial cells
from human pluripotent stem cells [35]. Using a completely
different cellular model, this study elegantly shows that still
immature endothelial cells can further differentiate towards a BBB
phenotype under appropriate culture conditions and that contact
with neural cells is crucial for this specialization. This robust
specialization model, which includes well-organized TJs, expres-
sion of nutrient transporters, polarized efflux transporter activity
and a high TEER is based on genetically reprogrammed cells. The
main advantage of this model is that it leads to an abundant source
of differentiated BBB cells, to perform drug screening for example.
However, this model has a number of limitations related to the use
of these pluripotent cells, which are genetically reprogrammed.
Moreover, epigenetic modifications, which persist after repro-
gramming, would impact on the application of these cells in basic
research or drug development [37,38]. The model proposed in our
study, although presenting a less complete BBB phenotype, is still
the first proposed model using primary normal human endothelial
progenitors, which could ultimately lead to a new in vitro model of
the human BBB. The large amount of early passage EPDCs
obtained from umbilical cord blood allows appropriate conditions
to perform drug testing. Moreover, cord blood, an accessible
source for EPC, gives access to the study of inter-individual
biological variabilities, which constitutes an important asset for
pharmaceutical studies. In any event, both models may constitute
original tools for producing human in vitro models for drug testing.
To extend the concept of specialization of early passage EPDCs,
we assessed their response to culture conditions leading to an
arterial specialization. Indeed, after identification of a new set of
arterial markers differentially expressed by HUAECs and
HUVECs, we showed here that high concentrations of VEGF
induced early passage EPDCs to express a series of arterial
markers: VEGF-treated EPDCs expressed both classical (EPHB2,
DLL4, NOTCH3, HEY1 and HES1) and newly identified (ANGPT2,
CXCR4, MMP9 and CD34) arterial markers.
Although the new genes we identified were not precisely
described as arterial markers in other studies, previous reports
were consistent with our study. Indeed, expression of PlGF, which
is induced by more than 4 fold in HUAECs as compared to
HUVECs, was detected in several types of cultured human
endothelial cells; PlGF expression, production and secretion was
reported to be higher in Human Pulmonary Arterial Endothelial
Cells than in HUVECs, supporting the arterial specificity of this
marker [39]. We also showed that CXCR4, CD34 and ANGPT2
expressions were significantly increased in HUAECs and in
EPDCs cultured in VEGF-inductive conditions, compared to
HUVECs. CXCR4, which is the receptor of the SDF1 (CXCL12)
Figure 6. Immunofluorescence analysis of arterio-venous markers in EPDCs under arterial and venous inductive conditions. (A)
EPDCs were cultured under high or low VEGF concentrations. (B) High VEGF early passages EPDCs were cultured with 50 mM DAPT (red: arterial
markers, bleu: venous markers).
doi:10.1371/journal.pone.0084179.g006
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chemokine, was detected in endothelial cells of the dorsal aorta but
not of cardinal veins in the aorta-gonado-mesonephros (AGM)
region of E11.5 mouse embryos, confirming an arterial specificity
of the gene [40]. Moreover, immunohistochemical analysis of the
CD34 antigen expression has shown a strong expression in large
vessels of the umbilical cord, especially in arteries [41], which
correlates with our results. Finally, a recent study has demonstrat-
ed that the ANGPT2 gene was up-regulated in rat mesenteric
microvascular arteries compared to veins [42].
It is well known that VEGF is required for arterial specializa-
tion. It has been shown, particularly in zebrafish, that sonic hedgehog
acts upstream of VEGF by inducing the latter’s expression [33].
The Notch signaling pathway is crucial for arterial differentiation
by acting downstream of VEGF induction [24,25]. Indeed, we
confirmed here that VEGF-induce arterial specialization of
EPDCs depended on Notch signaling. Incubation of VEGF-
treated cultures with a Notch inhibitor (DAPT) strongly repressed
the expression of most arterial markers and increased that of
venous markers. These results indicate that the EPDCs arterial
specialization model proposed here involves canonical molecular
pathways such as VEGF and Notch signaling, via the Notch3
receptor. Moreover, we showed that culture under flow conditions
is not obligatory for establishing an arterial profile, although it is
probably required for its maintenance during further passages.
Indeed, arterial-venous development and specification in the
embryo has been assumed to depend on the influence of fluid
mechanical forces [43,44]. Masumura et al. have demonstrated
that shear stress induces an increase in expression of the arterial
endothelial marker EphrinB2 in murine ES cells via the VEGF-
Notch signaling pathways [27]. Moreover, when cultured EPCs
were exposed to shear stress, the gene expression levels of the
arterial endothelial markers ephrinB2, Notch1/3, Hey1/2, and
ALK1 increased, whereas the gene expression levels of the venous
endothelial markers EphB4 and NRP2 decreased [45]. Although
Notch1 and Notch4 are known to be expressed in arterial
endothelial cells, it appears that Notch3 is the receptor involved in
the arterial specialization of EPDCs by VEGF and/or shear stress
induction [25,45–47].
In summary, the present study illustrates that EPDCs grown
under specific instructive culture conditions can further differen-
tiate towards specialized phenotypes. We propose that EPDCs
may now be considered as a promising source of plastic
endothelial cells, capable of acquiring distinct tissue specific
characteristics which may benefit drug testing and to the
development of predictive in vitro assays.
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